Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.
The trial is the first to test a hydrogel designed to repair cardiac tissue. It is also the first to test a hydrogel made from the natural scaffolding of cardiac muscle tissue, also known as extracellular matrix, or ECM. This is significant because ECM hydrogels have been shown in preclinical studies to potentially be effective for other conditions, such as poor blood circulation due to peripheral artery disease. The trial showed that the hydrogel, known as VentriGel, can be safely injected via catheter into patients who had suffered a heart attack in the past 2 to 36 months.
“Although the study was designed to evaluate safety and feasibility and not designed to show whether VentriGel effectively helps improve heart function, we observed some improvements in patients,” said Karen Christman, the paper’s senior author and a professor of bioengineering in the Jacobs School of Engineering and the Institute of Engineering in Medicine at UC San Diego. “For example, patients could walk longer distances. We also observed signs of improving heart function in patients who experienced a heart attack more than one year prior to treatment.”
Researchers from Ventrix, led by Christman, report their findings in the Sept. 11 issue of the Journal of the American College of Cardiology: Basic to Translational Science. Dr. Jay Traverse from the Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital was the lead clinical investigator.
There are an estimated 785,000 new heart attack cases in the United States each year, with no established treatment for repairing the resulting damage to cardiac tissue. After a heart attack, scar tissue develops, which diminishes muscle function and leads to heart failure. This is where VentriGel comes in. Once injected in damaged cardiac muscle, VentriGel forms a scaffold that acts as a reparative environment where healthy cells migrate, leading to increases in cardiac muscle, less scar tissue, and improvements in heart function.
VentriGel was invented by Christman and her team, then licensed from UC San Diego and developed by Ventrix, Inc, which was cofounded by CEO Adam Kinsey and Christman.
VentriGel is made from cardiac connective tissue taken from pigs, which is stripped of heart muscle cells through a cleansing process. It is then freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into heart muscle in a minimally invasive procedure that does not require surgery. Once it hits body temperature, the liquid turns into a semi-solid, porous gel.
The Phase 1 trial evaluated the gel in 15 patients who sustained moderate damage in the left ventricle chamber of the heart following a heart attack. Each patient received up to 18 injections of VentriGel into the damaged region via catheter. Researchers followed the patients for six months after treatment. All patients completed the full follow-up.
Twelve of the 15 patients were men. All 15 were experiencing mild to moderate heart failure following a heart attack. Half had suffered a heart attack within the past year.
Patients took a six-minute walking test as well as a heart function assessment and a heart health questionnaire before the injections. They retook the tests three and six months later. In addition, patients underwent an MRI at three and six months after the procedures.
Ventrix is now gearing up for a Phase 2 clinical trial that will expand on this successful first-in-human study. They are planning a larger, randomized trial that will evaluate how effectively VentriGel can improve cardiac function and quality of life for patients experiencing heart failure.
Learn more: FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans—A First
The Latest on: Heart repair
[google_news title=”” keyword=”heart repair” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Heart repair
- Diesel repair shop faces hefty fines for illegally disabling vehicle pollution monitoring devices: 'EPA will vigorously prosecute those who violate laws'on April 27, 2024 at 3:15 am
"The defendants in this case illegally tampered with the onboard diagnostics systems and removed the emissions control components from hundreds of diesel trucks." Diesel repair shop faces hefty fines ...
- Heart, Wound, and Inflammation Research and TB-500 Peptideon April 27, 2024 at 1:12 am
Researchers interested in exploring the possible properties of the TB-500 peptide will ...
- 4-year-old who received new heart after waiting 1,025 days goes home from hospitalon April 26, 2024 at 10:43 am
According to her parents and doctor, 4-year-old Arctura was born with a congenital heart defect, which the Centers for Disease Control and Prevention notes is the most common type of birth defect.
- JPMorgan CEO Jamie Dimon reveals he has ‘PTSD’ from ‘near death’ heart surgery: ‘I knew it was 50/50’on April 26, 2024 at 8:43 am
JPMorgan Chase CEO Jamie Dimon admitted that he has “PTSD” from a “near death” heart surgery that took place in 2020. “When I was being wheeled in the operating room ...
- LaVale man gets national recognition for heart valve replacement survivalon April 26, 2024 at 6:20 am
Seth Wharton was 13 years old when he awoke after open-heart surgery and asked his parents if he'd be able to play football. Because he was born with a serious heart problem, doctors said he should ...
- McKay-Dee Hospital doctors excited about new treatment for heart failure patientson April 25, 2024 at 5:00 pm
Cardiologists at Intermountain McKay-Dee Hospital are now performing a procedure on patients with heart failure they say is not only improving lives, but saving them as well. MitraClip is a tiny clip ...
- Heart Disease Newson April 24, 2024 at 5:00 pm
Cardiology Team Performs Novel Heart Artery Repair With Newly Approved Device Apr. 9, 2024 — Medical researchers have performed a successful transcatheter tricuspid valve repair procedure with a ...
- New HMD Phones Combine Low Price With DIY Repair and Battery Replacementon April 24, 2024 at 8:43 am
Nokia-maker HMD has unveiled its first own-brand phone series. All three of the HMD Pulse devices have repairability at their heart.
- Computational models forecast pediatric heart valve leakageon April 24, 2024 at 6:00 am
New computational models simulate heart valve shape, possible weak spots, and blood flow to help predict potential issues and guide surgery-based preventive efforts.
- How quality sleep can reduce the risk of heart disease and strokeon April 22, 2024 at 4:59 pm
“The link between adequate sleep and heart health is increasingly recognized as vital. Sleep serves as a period of recovery and repair for the heart, reducing stress and inflammation, major risk ...
via Bing News